Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

BACKGROUND: Guidelines endorse statin therapy for lowering low-density lipoprotein cholesterol (LDL-C) to recommended levels, in patients with cardiovascular disease (CVD) risk, if needed, after lifestyle changes. Atorvastatin is a common statin with greater LDL-C lowering efficacy than most other s...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrett, Elizabeth, Zhao, Changgeng, Zhang, Ning Jackie, Zhang, Qiaoyi, Ramey, Dena R, Tomassini, Joanne E, Tershakovec, Andrew M, Neff, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008284/
https://www.ncbi.nlm.nih.gov/pubmed/24851051
http://dx.doi.org/10.2147/VHRM.S54886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008284/
https://www.ncbi.nlm.nih.gov/pubmed/24851051
http://dx.doi.org/10.2147/VHRM.S54886

Ejemplares similares